Cross-Species Cancer Comparison Uncovers New Drug Targets, Study Reveals

New drug targets for a rare form of melanoma may result from the discovery of similar genetic mutations found in humans, dogs and horses under a first-ever tri-species DNA sequencing study involving a University of Guelph researcher.

Comparing cancers across species may help in pinpointing the most relevant drug targets, said pathobiology researcher Geoffrey Wood, assistant co-director of U of G’s Institute for Comparative Cancer Investigation (ICCI).

 | OVC BulletinU of G News